This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Intuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical
by Zacks Equity Research
Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.
Top Analyst Reports for AMD, Abbott Laboratories & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).
Why Intuitive Surgical, Inc. (ISRG) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intuitive Surgical (ISRG) Preliminary Q4 Revenues Improve Y/Y
by Zacks Equity Research
Intuitive Surgical's (ISRG) fourth-quarter revenues reflect a strong demand in procedure volume as China recovers following the resurgence of COVID-19 in early 2023.
Strength Seen in Intuitive Surgical, Inc. (ISRG): Can Its 10.3% Jump Turn into More Strength?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Company News for Jan 11, 2024
by Zacks Equity Research
Companies In The News Are: WDFC, ETWO, LEN, ISRG.
Markets Trade Higher Ahead of Thursday's CPI
by Mark Vickery
Core CPI year over year looks to shed 20 bps to +3.8%, which would be the lowest print since the latter half of 2021.
Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $328.86, marking a +1.97% move from the previous day.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Inogen (INGN) Soars 15.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Here's Why Intuitive Surgical, Inc. (ISRG) Fell More Than Broader Market
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $330.98, signifying a -1.89% move from its prior day's close.
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $337.47, signifying a +0.02% move from its prior day's close.
Intuitive Surgical, Inc. (ISRG) Laps the Stock Market: Here's Why
by Zacks Equity Research
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $328.42, representing a +1.25% change from its previous close.
Intuitive Surgical, Inc. (ISRG) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $315.43, representing a +1.61% change from its previous close.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Intuitive Surgical, Inc. (ISRG) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $309.52, indicating a -0.74% shift from the previous trading day.
Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Intuitive Surgical, Inc. (ISRG) Stock Moves -0.06%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $310.76, denoting a -0.06% change from the preceding trading day.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Is Integra (IART) Up 10.2% Since Last Earnings Report?
by Zacks Equity Research
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.